Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

NCT02489916 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: CM4307

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd